iGC-SEA now supports 21CFR Part 11

With its release in 1997 of 21 CFR Part 11, the FDA specified its requirements for accepting electronic records in lieu of paper records. It is beneficial in future to design a discovery automation system to comply with Part 11 and to further codify the requirements for drug discovery records. If it does so, it is likely that the requirements will follow the same standards as Part 11. 

inverse gas chromatography - surface energy analyzer (iGC-SEA)


    I would also like to receive a quote for this product/analysis

      Request a quote

      Watch past webinar